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Introduction
Clinical research in pneumonia involves the creation and
dissemination of new knowledge studying patients with
pneumonia. The process of clinical research can be summarized
in four steps: planning the study, performing of the study,
analyzing the data, and disseminating study results. During
the third step of data analysis, data are often examined to
define if associations exist between independent variables
(e.g. predictor variable or other variables in the model) and
the dependent variable (e.g. outcome). This examination of
the data is performed using two types of methods: 1) clinical
analysis and 2) statistical analysis. During clinical analysis, the
data are evaluated to define biological plausibility and clinical
importance. During statistical analysis, the data are commonly
evaluated to define statistical significance for the purposes of
hypothesis testing, an approach termed ‘frequentist statistics’
[1].
Several limitations are recognized with the use of these
traditional frequentist approaches in clinical research. The
overemphasis on hypothesis testing, calculation of P-values
as the primary means of significance assessment, and the
convention of using the 5% level of statistical significance are
all now considered limiting issues for defining causal effects;
the actual impact of the independent variable (predictor) on the
dependent variable (outcome). Here, the approach to analysis is
based only on two mutually exclusive hypotheses, the null and
alternative hypotheses, with results being either significant or
nonsignificant. This leads to either rejecting the null hypothesis
(significant P-value) or not rejecting the null hypothesis (nonsignificant P-value). Statistically significant P-values, those
below an arbitrary cut point (often 0.05), can be obtained when
the sample sizes are large but actual differences or associations
are small (and potentially not clinically meaningful). On the
other hand, non-significant results (e.g. P values over the cutoff)
may be due to a small sample of patients (often termed lack of
statistical power), or true non-significance. Therefore, when
non-significant results are obtained using traditional hypothesis
testing, it is not known if the results are due to the sample size
(leading to reduced statistical power to detect the association or
difference), or there truly is no association or difference between
the predictor variable and the outcome.
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Here, we propose adding machine learning, a branch of artificial
intelligence, as a new methodology to analyze study results in
pneumonia clinical research. Currently, few investigators use
these methods as a replacement for traditional frequentist
statistical methodologies.
Machine learning in small datasets
Until recently machine learning methods were considered
useful only for ‘big data’ (e.g. millions of patients and hundreds
of variables), and were used for purely predictive modeling
(versus explanatory modeling). This led to most machine
learning approaches being labeled as ‘black boxes’. These black
boxes were very accurate at predicting an outcome for a new
individual after being trained on historical data, but were not
able to provide an estimate of the impact of each variable on the
outcome. This latter concept (explanatory modeling) has been a
necessary part of clinical research for many decades. However,
machine learning can now be used to estimate the impact of
each variable on the outcome using a few novel methods. Newer
algorithms are also much better at dealing with the smaller
datasets typically available in pneumonia clinical research.
One of the most useful developments in the area of machine
learning is causal forests and a limited number of other methods
(Bayesian trees, Gaussian processes for machine learning,
causal multivariate adaptive regression). These methods allow
for the direct calculation of treatment effects, the effect of the
predictor variable on the outcome. This can be particularly
useful in the case of a negative study, when the results are
inconclusive or suggest that the intervention is not effective.
In these negative studies, there may be subpopulations or
clusters of individuals who will have a different and sometimes
clinically meaningful treatment effect. Some subpopulations
may even result in opposite associations between predictor and
outcome. This differential treatment effect among subsamples
is termed ‘heterogeneous treatment effects’, and can now be
identified using machine learning methods. Although one can
use traditional methods to identify subpopulations through
stratified regression modeling or inclusion of interaction terms
(to detect effect modification), the investigator will run into
issues with multiple testing bias, a common pitfall in frequentist
statistics. In those hypothesis testing-driven methods, each
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Table 1 Summary of methods
Method

Description

Frequentist Statistics
Hypothesis Testing

Input data either rejects a null hypothesis or not,
usually using a 5% level of significance

Machine Learning
Decision Trees

A tree structure of decisions regarding input data is
created and paths can be followed to make a
prediction

Support Vector Machines

Input data is separated into 2 classes to make
predictions and generalizations about each class

Artificial Neural Networks

A series of connections modeling the human brain are
given input data and trained iteratively to make
predictions

Deep Learning

Many more layers of connections are used to train the
neural network to increase the accuracy of its
predictions

additional test run on the data increases the amount of
statistical error present. Therefore, if an investigator wishes to
evaluate ten different variables as potentially providing different
effects among the study sample, the level of statistical error
increase substantially. At the most conservative, one can use
the Bonferroni correction to account for this. In this approach,
the cutoff for statistical significance (again, typically 0.05) is
divided by the number of tests run, allowing for identification
of a new cutoff. Here, 0.05/10 = 0.005. Therefore, no variable
in the models could be considered significant until the P-value
is below that new threshold. Given the typical sample sizes in
pneumonia clinical research, this is unlikely to occur, even if
there is a true and large treatment effect in the data. Our novel
machine learning methods do not suffer from this issue, as they
are not focused around hypothesis testing, rather algorithmic
approaches to defining treatment effects. Because of this,
one can evaluate as many variables as they wish for defining
heterogeneous treatment effects without increasing error.
Machine learning algorithms
The term machine learning is an umbrella term comprising
multiple computational methods. These methods are often
combined with traditional frequentist statistical approaches
such as bivariable tests, basic general linear models including
logistic regression, leading some individuals to prefer the phrase
“Statistical Learning”. For the purposes of this paper, we will use
machine learning.
One can think of machine learning as a set of tools used to
algorithmically compute a prediction for a clinical outcome.
Often the outcome is binary, such as the presence versus
absence of a disease or mortality versus survival; however, an
outcome also can be multiclass such as a risk score like the
Pneumonia Severity Index [2].

Figure 1 Sample Decision Tree

Decision Tree
Decision tree algorithms determine how to split a dataset into a
tree structure that can be followed from the top of the tree to the
bottom to make a prediction. Decision trees are already widely
used in epidemiological and clinical research. For example,
consider a small dataset with variables gender (M/F), trouble
breathing (Y/N), and cough (Y/N); the outcome is whether or
not a person has the common cold. A decision tree algorithm
uses the dataset to “learn” the rules and build the tree for predict
the outcome (Figure 1).
Several algorithms exist for creating decision trees including
ID3 [4], C4.5 and CART [5].These approaches have been further
enhanced to reduce error in the computation with ensemble
decision trees in which multiple trees are generated from the
data and their results averaged. Examples include random
forests, extreme gradient boosted machines, and causal forests.
In fact, CART and random forests can be used for propensity
score generation to overcome some of the limitations of logistic
regression [6].
Support Vector Machine
A Support Vector Machine is a machine learning technique that
seeks optimal separation between two classes of data. SVMs
calculate a margin, which is the largest region that separates
two classes (Figure 2). The margin is also called the separating
hyperplane. Imagine using a piece of paper placed on its edge
on the line in Figure 2. The paper would cleanly separate these
classes with the margin being the largest distance possible
between the classes.

Logistic regression is widely used for analysis in clinical
research. However, it suffers from several problems including
difficulty with interpreting log-odd or odds ratios, comparing
log-odd ratios calculated with different independent variables,
and comparing log-odds and odds ratios across subgroups in
the sample, even if they use the same independent variables
[3]. Several machine learning algorithms are available that can
also be used that overcome some of the problems of logistic
regression. These include, but are not limited to, Decision
Trees, Support Vector Machines, Artificial Neural Networks,
and Deep Learning (Table 1).
Figure 2 Support Vector Machine - margin
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SVM works particularly well for problems that are linear, but can
also be used on non-linear problems if they can be transformed
into a representation that supports a separating hyperplane. For
example, in Figure 3-a, no line can be drawn through the data
to separate two classes. However, if the data were transformed
into a “bowl” shape, a line can be drawn to separate them
(Figure 3-b). The algorithm then can determine which class a
data point belongs (Figure 3-c). The mathematical transforms
to convert non-linear data into linear are called kernels. Several
kernels exists for various linear and non-linear problems
including, linear, nonlinear, polynomial, radial basis function
(RBF), and sigmoid.
Figure 5 Deep Learning Artificial Neural Network

Figure 3 Support Vector Machine - transformation

One significant limitation of SVMs is that they are inherently
binary classifiers. To accomplish multi-classification, they are
typically run one against everything else and results of each
classification compared. For example, if determining risk
classification with four levels, SVM would classify the first level
against all others, the second level against all others and so
on. Like logistic regression, SVM also can be used to generate
propensity scores. However, they are not as effective as boosting
and decision trees [6].
Artificial Neural Networks
Artificial Neural Networks (ANN) model the human brain. The
input data are represented as a set of nodes that connect to one
or more hidden layers of nodes called neurons. The hidden layer
then connect to an output layer that provides the result (see
Figure 4).
The connections between each neuron (the lines in Figure 4)
have weights that control whether or not a neuron “fires”. Using
a mathematical technique called gradient descent, the a neural
network algorithm “learns” the optimal set of weights to fire the

appropriate neurons that will discriminate between different
classes by produce a 1 or 0 at the output layer. One advantage
of ANNs over some of the other machine learning algorithms is
that they train on the same dataset multiple times. Therefore,
there is less of an effect on the training if the dataset is small.
Furthermore, ANNs can model linear and non-linear problems.
The are several other models of ANNs including recurrent
neural networks in which nodes later in the model (toward the
right side in Figure 4) can be connected to previous layers.
Deep Learning
An extension to the ANN is the Deep Artificial Neural Network
often just called Deep Learning. Traditional ANNs only use a
few hidden layer, usually ten or less. To model the human brain
more effectively, the number of hidden layers can be expanded
to several hundred layers. While this still doesn’t approach the
size of the networks in the human brain, deep learning has
proven to be effective for many categorization tasks and pattern
matching (Figure 5) [7].
The primary disadvantages of ANNs and Deep Learning is
interpretability and overfitting. With linear regression and
logistic regression, the coefficients can be interpreted, although
as previously discussed, it is more complicated for logistic
regression. With any form of neural network, the feature of the
network that is optimized are the weights between the neurons.
There is no straightforward way to explain how the weights
affect the prediction. In contrast, I decision tree, even if large,
has paths that can be followed to show how the outcome is
derived. Overfitting, in which the ANN learns the training data
extremely well, but does not generalize to other data is another
significant problem. This can be addressed with regularization
which is a common mathematical technique that adds data to
the model so it better generalizes to other data.

Conclusions
When analyzing an association in clinical research, our
traditional statistical methods, or frequentist statistics, are too
rigid. The results are either significant or nor significant and the
study is either positive or negative. One important advantage
of machine learning will be our capability to better evaluate
effects of interventions in study subpopulations. We think that
the adoption of machine learning in clinical research will open
a new and more productive way to analyze study results. Our
capacity for interpretation of data and the generation of study
conclusions will be enhanced by machine learning.
Figure 4 Artificial Neural Network
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